Efficacy and Safety of 3- and 5-Injection Patterns (30 and 50 U) of Botulinum Toxin A (Dysport) for the Treatment of Wrinkles in the Glabella and the Central Forehead Region

Authors:
  • BABenjamin Ascher
    Benjamin Ascher
  • AFAlina Fratila
    Alina Fratila
  • GMGary D. Monheit
    Gary D. Monheit
  • STSergio Talarico
    Sergio Talarico
  • WSWolfram Sterry
    Wolfram Sterry

Abstract
Botulinum toxin A has been used successfully for esthetic purposes for almost 2 decades, although only a few clinical trials supporting its use have been published so far,1-3 and most of the evidence is in the form of case series. Dysport (Ipsen Pharma, Ettlingen, Germany), the brand of botulinum toxin A used in this study, has been available for more than a decade in Europe and is registered for various neurological indications. The product has been used “off label” in dermatology,4-8 a field in which there is considerable practical experience with its cosmetic use but few controlled trials reporting its efficacy and safety to date.

This publication has 6 references indexed in Scilit: